Navigation Links
Pregnant Women With Placental Infection Have Doubled Risk of Recurrence

Pregnant women who develop an infection of the placenta or nearby membranes in their first pregnancy have twice the risk of getting it in their second pregnancy, researchers// at UT Southwestern Medical Center have found.

The infection, called chorioamnionitis, occurs in 0.5 percent to 10 percent of births. It can cause bleeding and widespread infection in the mother and infect the fetus as well, possibly resulting in cerebral palsy. If the infection develops during gestation, the baby must be delivered immediately, sometimes prematurely, to protect its health. Mother and child can then be treated with antibiotics.

The longer the time between the amniotic sac (waters) breaking and birth, the higher the risk for the infection at the time of birth. The infection can also take root before the waters break.

The study, which involved reviewing the records of 28,410 women who gave birth at Parkland Memorial Hospital, indicates that there may be one or more intrinsic risk factors that predispose women to the infection, the researchers report. Those might be the genetic makeup of their immune response or stronger bacteria in their genital tracts, they said.

“We do believe that there probably is a genetic component that predisposes women to intrauterine infection,” said Dr. Vanessa Laibl, assistant professor of obstetrics and gynecology at UT Southwestern and lead author of the study. “We also believe that certain women could be colonized with bacteria that are more virulent and more likely to cause infection.”

The report, appearing in the December issue of Obstetrics and Gynecology, is the largest clinical study to address the topic, Dr. Laibl said.

The researchers focused on women who had vaginal deliveries of a single baby in their first pregnancy. Of those, 10 percent developed chorioamnionitis.

The women who developed the infection in their first pregnancies tended to have longer labors, pr
'"/>




Page: 1 2

Related medicine news :

1. Pregnant smokers could harm their child
2. Risk for Pregnant Women
3. Pregnant women more prone to depression
4. The Effects Of Fish On Pregnant Women Questioned
5. Relieving Pelvic Pain In Pregnant Women
6. Pregnant mothers dental health can lead to pre-term babies
7. Listeria Food Poisoning Can Be Dangerous In Pregnant Women And Elderly
8. The Dangers Of Vitamin A To Pregnant Women To Be Included On Label
9. Trained Counselors Counseling Pregnant Smokers To Quit May Not Work
10. Good Response from Pregnant Women in Delhi for Free ART Therapy
11. London Hospital Provides Specialized Care For Pregnant Women
Post Your Comments:
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Catholics for Choice Statement on Healthcare Reform Bill 60931 1Catholics for Choice Statement on Healthcare Reform Bill 60931 2Findings show nanomedicine promising for treating spinal cord injuries 10653 1Findings show nanomedicine promising for treating spinal cord injuries 10653 2Findings show nanomedicine promising for treating spinal cord injuries 10653 3APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 60929 1APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 60929 2